Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07185451 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Efficacy and Safety of Transcranial Alternating Current Stimulation (tACS) Combined With Stable Medication in Adolescents With Depression

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Mar 30, 2026 → Mar 30, 2027
Primary endpoint removed 5 → 4 primary endpoints
Primary endpoints added 1 → 5 primary endpoints
See other at-risk trials from First Affiliated Hospital of Chongqing Medical University

Record History

  1. Primary endpoint(s) modified Eligibility criteria expanded, about 14 words · Secondary endpoints shortened, about 85 words · Study description expanded, about 85 words · 1 more Show 4 more changesShow less
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints shortened, about 85 words
    • Study description expanded, about 85 words
    • Publications: details revised at 13 of 13 entries
  2. Primary completion pushed from Mar 30, 2026 to Mar 30, 2027 Primary endpoint(s) modified · Recruitment opened · Completion pushed from Oct 1, 2026 to Oct 1, 2027 · 4 morev2 Show 7 more changesShow less
    • Primary endpoint(s) modified
    • Recruitment opened
    • Completion pushed from Oct 1, 2026 to Oct 1, 2027
    • Secondary endpoints: 8 to 9
    • Study description shortened, about 8 words
    • Site details revised
    • Study title shortened, about 6 words

    See this version in full on ClinicalTrials.gov ↗

  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized, double-blind, sham-controlled pilot study will evaluate the feasibility, acceptability, safety, and preliminary clinical effects of transcranial alternating current stimulation as an adjunctive treatment for adolescents with major depressive disorder. The study will also explore changes in clinical symptoms, cognitive performance, and brain function following the intervention.
Trial Details
NCT Number NCT07185451
Lead Sponsor First Affiliated Hospital of Chongqing Medical University
Conditions Depression - Major Depressive Disorder
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov